Journey Medical Corp expected to post a loss of 15 cents a share - Earnings Preview

Journey Medical

04/11/2023 03:05

* Journey Medical Corp  DERM.OQ   DERM.O  is expected
to show a
rise in quarterly revenue when it reports  results 
    * The Scottsdale Arizona-based  company is expected to
report  a
4.7% increase in revenue to $16.879 million from $16.12 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Journey Medical
Corp is
for a loss of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Journey
Medical
Corp is $6.5​, above​ its last closing price of $3.45. ​​​

This summary was machine generated November 4 at 03:04 GMT.  All
figures in US dollars  unless otherwise stated